| Company | Designation | Period |
|---|---|---|
| Director | 20 Jul 2020 | U85200TG2020NPL141954 – Present |
| Director | 30 Aug 2013 | U85100TG2008PTC057669 – Present |
| Director | 10 Jul 2012 | U45100TG2012PLC081892 – Present |
| Director | 26 Sep 2001 | U29219TG1989PLC009683 – Present |
| Director | - | U24304AP2020PTC116442 – Present |
| Director | - | U24299AP2020PTC116443 – Present |
| Director | 21 Aug 2023 | U24298TG2017PTC121342 – Present |
| Director | 19 Dec 2006 | U24239TG2006PLC052053 – Present |
| Additional Director | 18 Sep 2009 | U24239TG2004PLC044102 – Present |
| Director | 28 Nov 2013 | U24232TG2013PLC091383 – Present |
| Director | 16 Sep 2013 | U24232TG2010PTC069638 – Present |
| Director | 15 Sep 2006 | U24116TG2006PLC051171 – Present |
| Director | 30 Nov 2006 | U24110TG1993PTC016703 – Present |
| Director | 26 Dec 2022 | U24110AP2020PTC115965 – Present |
| Managing Director | 30 Dec 1992 | L24239TG1986PLC015190 – Present |
| CIN/LLP | Company | Designation | Date |
|---|---|---|---|
| Aurobindo Pharma Ltd | Managing Director | 30 Dec 1992 | L24239TG1986PLC015190 |
| Aurobindo Antibiotics Private Limited | Director | 26 Dec 2022 | U24110AP2020PTC115965 |
| Senor Organics Pvt Ltd | Director | 30 Nov 2006 | U24110TG1993PTC016703 |
| Apl Research Centre Limited | Director | 15 Sep 2006 | U24116TG2006PLC051171 |
| Hyacinths Pharma Private Limited | Director | 16 Sep 2013 | U24232TG2010PTC069638 |
| Aurozymes Limited | Director | 28 Nov 2013 | U24232TG2013PLC091383 |
| Trident Life Sciences Limited | Additional Director | 18 Sep 2009 | U24239TG2004PLC044102 |
| Apl Healthcare Limited | Director | 19 Dec 2006 | U24239TG2006PLC052053 |
| Apitoria Pharma Private Limited | Director | 21 Aug 2023 | U24298TG2017PTC121342 |
| Lyfius Pharma Private Limited | Director | - | U24299AP2020PTC116443 |
| Qule Pharma Private Limited | Director | - | U24304AP2020PTC116442 |
| Pattancheru Enviro-Tech Limited | Director | 26 Sep 2001 | U29219TG1989PLC009683 |
| Raidurgam Developers Limited | Director | 10 Jul 2012 | U45100TG2012PLC081892 |
| Silicon Life Sciences Private Limited | Director | 30 Aug 2013 | U85100TG2008PTC057669 |
| Aurobindo Pharma Foundation | Director | 20 Jul 2020 | U85200TG2020NPL141954 |
| CIN/LLP | Company | Designation | Period |
|---|---|---|---|
| Curateq Biologics Private Limited | Additional Director | 02 May 2020 | – |
| Auro Peptides Limited | Director | 02 Jan 2012 | – |
| Curepro Parenterals Limited | Director | 19 Apr 2013 | – |
| Pharmaceuticals Export Promotion Council Of India | Director | 13 Apr 2004 | – |
| Auronext Pharma Private Limited | Director | 30 Jul 2010 | – |
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Official Email: Via Aurobindo Pharma corporate communication desk.
Personal Contact: Not publicly disclosed.
What is Nityanand Reddy 's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Aurobindo Pharma's official communication channels.
Is this an official profile?
No — independently created using public data.
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)